13 Dec 2023 --- Health and nutrition player, dsm-firmenich reveals it has been granted EU market access for its novel 3-fucosyllactose (3-FL) human milk oligosaccharide (HMO) ingredient. This development comes as the European Commission (EC) has also approved 3-FL as a novel food ingredient, following a successful application submitted by Glycom.
